CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression
2019 · Cell Death and Disease · 228 citations
https://doi.org/10.1038/s41419-019-2089-9
Z
Zebing Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
1.8K
Citations
22
h-index
35
i10-index
Zebing Huang is an academic researcher from Central South University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Hepatitis C virus research. The author has an h-index of 22, co-authored 49 publications.
ORCID: 0000-0002-3403-8758Papers by this author
worksRhein and rhubarb similarly protect the blood-brain barrier after experimental traumatic brain injury via gp91phox subunit of NADPH oxidase/ROS/ERK/MMP-9 signaling pathway
2016 · Scientific Reports · 62 citations
https://doi.org/10.1038/srep37098
A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1
2018 · Cell Death and Disease · 62 citations
https://doi.org/10.1038/s41419-018-1231-4
Tryptophan-sorbitol based carbon quantum dots for theranostics against hepatocellular carcinoma
2022 · Journal of Nanobiotechnology · 51 citations
https://doi.org/10.1186/s12951-022-01275-2
Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study
2020 · Infectious Diseases and Therapy · 48 citations
https://doi.org/10.1007/s40121-020-00362-x
VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
2022 · Journal of Translational Medicine · 45 citations
https://doi.org/10.1186/s12967-022-03416-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat